BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15962637)

  • 1. One year study of Implanon on the adverse events and discontinuation.
    Chaovisitsaree S; Piyamongkol W; Pongsatha S; Morakote N; Noium S; Soonthornlimsiri N
    J Med Assoc Thai; 2005 Mar; 88(3):314-7. PubMed ID: 15962637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital.
    Aisien AO; Enosolease ME
    Niger J Clin Pract; 2010 Sep; 13(3):331-5. PubMed ID: 20857796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and clinical safety of Implanon.
    Blumenthal PD; Gemzell-Danielsson K; Marintcheva-Petrova M
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():29-36. PubMed ID: 18330815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.
    Wong RC; Bell RJ; Thunuguntla K; McNamee K; Vollenhoven B
    Contraception; 2009 Nov; 80(5):452-6. PubMed ID: 19835719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year assessment of women receiving sub-dermal contraceptive implant at Siriraj Family Planning Clinic.
    Thamkhantho M; Jivasak-Apimas S; Angsuwathana S; Chiravacharadej G; Intawong J
    J Med Assoc Thai; 2008 Jun; 91(6):775-80. PubMed ID: 18697372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive efficacy and side effects of Implanon.
    Gezginc K; Balci O; Karatayli R; Colakoglu MC
    Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):362-5. PubMed ID: 17853166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implanon sub-dermal implants: a 10-month review of acceptability in Jos, North-Central Nigeria.
    Mutihir JT; Daru PH
    Niger J Clin Pract; 2008 Dec; 11(4):320-3. PubMed ID: 19320403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey.
    Yildizbas B; Sahin HG; Kolusari A; Zeteroglu S; Kamaci M
    Eur J Contracept Reprod Health Care; 2007 Sep; 12(3):248-52. PubMed ID: 17763263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discontinuation rate and reasons for discontinuation of implanon at the family planning clinic of University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria.
    Ezegwui HU; Ikeako LC; Ishiekwene CI; Oguanua TC
    Niger J Med; 2011; 20(4):448-50. PubMed ID: 22288321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant.
    Croxatto HB
    Eur J Contracept Reprod Health Care; 2000 Sep; 5 Suppl 2():21-8. PubMed ID: 11246604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.
    Weisberg E; Hickey M; Palmer D; O'Connor V; Salamonsen LA; Findlay JK; Fraser IS
    Hum Reprod; 2006 Jan; 21(1):295-302. PubMed ID: 16284061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of implanon in the symptomatic treatment of endometriosis.
    Ponpuckdee J; Taneepanichskul S
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S7-10. PubMed ID: 17722311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.
    Harvey C; Seib C; Lucke J
    Contraception; 2009 Dec; 80(6):527-32. PubMed ID: 19913146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of Implanon on menstrual bleeding patterns.
    Mansour D; Korver T; Marintcheva-Petrova M; Fraser IS
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():13-28. PubMed ID: 18330814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria.
    Mutihir JT; Nyango DD
    East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
    Yao XY; Du MK
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jul; 38(7):419-22. PubMed ID: 12921554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A postmarketing observational study assessing acceptability and reliability of desogestrel only contrapceptive pill (Cerazette) in Indian women.
    Ray S; Sovani VB
    J Indian Med Assoc; 2006 Nov; 104(11):653-6. PubMed ID: 17444070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital.
    Laphikanont W; Taneepanichskul S
    J Med Assoc Thai; 2006 Jun; 89(6):761-6. PubMed ID: 16850674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with early discontinuation rate of Implanon utilization among women who ever used Implanon in Kucha District Gamo Gofa Zone, Southern Ethiopia.
    Mamecha Mesha ; Akalewold Alemayehu ; Deresse Daka
    BMC Womens Health; 2020 Oct; 20(1):239. PubMed ID: 33097056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.